Search

Author/Creator Udata, Chandrasekhar

1. A Mechanism‐Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development. (9th February 2017)

Authors:
Udata, Chandrasekhar; Garzone, Pamela D.; Gumbiner, Barry; Joh, Tenshang; Liang, Hong; Liao, Kai‐Hsin; Williams, Jason H.; Meng, Xu
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 7(2017)
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing. Issue 11 (11th May 2020)

Authors:
Liao, Kai H.; Udata, Chandrasekhar; Yin, Donghua; Sewell, K. Lea; Kantaridis, Constantino; Alvarez, Daniel F.; Meng, Xu
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 11(2020)
Page Start:
2182
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01). (3rd April 2018)

Authors:
Palaparthy, Ramesh; Udata, Chandrasekhar; Hua, Steven Y.; Yin, Donghua; Cai, Chun-Hua; Salts, Stephanie; Rehman, Muhammad I.; McClellan, Joseph; Meng, Xu
Journal:
Expert review of clinical immunology
Issue:
Volume 14:Number 4(2018)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗